I. A. Small

1.4k total citations
49 papers, 973 citations indexed

About

I. A. Small is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, I. A. Small has authored 49 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 13 papers in Surgery. Recurrent topics in I. A. Small's work include Lung Cancer Treatments and Mutations (13 papers), Gastric Cancer Management and Outcomes (11 papers) and Oral health in cancer treatment (7 papers). I. A. Small is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Gastric Cancer Management and Outcomes (11 papers) and Oral health in cancer treatment (7 papers). I. A. Small collaborates with scholars based in Brazil, United States and France. I. A. Small's co-authors include Carlos Gil Ferreira, Daniel Herchenhorn, Héliton Spíndola Antunes, Célia M. Viégas, Carlos M. Araújo, Fernando Luiz Dias, Mauro Zukin, Clarissa Baldotto, Luiz H. Araujo and Carlos H. Barrios and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

I. A. Small

46 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. A. Small Brazil	17	626	438	219	210	167	49	973
Carlo Gobitti Italy	16	507 0.8×	369 0.8×	160 0.7×	363 1.7×	266 1.6×	55	994
Daniel Herchenhorn Brazil	14	395 0.6×	205 0.5×	191 0.9×	178 0.8×	97 0.6×	47	575
Sushmita Pathy India	14	275 0.4×	247 0.6×	75 0.3×	93 0.4×	270 1.6×	62	677
B. Stein Australia	13	263 0.4×	1.1k 2.4×	59 0.3×	208 1.0×	158 0.9×	27	1.4k
Tran‐Der Tan Taiwan	13	166 0.3×	371 0.8×	45 0.2×	426 2.0×	340 2.0×	37	799
Liliana Belgioia Italy	15	289 0.5×	219 0.5×	106 0.5×	185 0.9×	161 1.0×	69	606
Ellie Maghami United States	17	396 0.6×	525 1.2×	92 0.4×	457 2.2×	359 2.1×	50	1.3k
Qin Zhou China	13	124 0.2×	128 0.3×	83 0.4×	112 0.5×	91 0.5×	39	457
Eligio Grigoletto Italy	14	221 0.4×	375 0.9×	34 0.2×	82 0.4×	119 0.7×	54	745

Countries citing papers authored by I. A. Small

Since Specialization

Citations

This map shows the geographic impact of I. A. Small's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. A. Small with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. A. Small more than expected).

Fields of papers citing papers by I. A. Small

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. A. Small. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. A. Small. The network helps show where I. A. Small may publish in the future.

Co-authorship network of co-authors of I. A. Small

This figure shows the co-authorship network connecting the top 25 collaborators of I. A. Small. A scholar is included among the top collaborators of I. A. Small based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. A. Small. I. A. Small is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silva, Jessé Lopes da, et al.. (2025). Unveiling the Landscape of PD-L1 Expression and Tumor-Infiltrating Lymphocyte Subtypes in Advanced Triple-Negative Breast Cancer in Brazil. Breast Cancer Targets and Therapy. Volume 17. 349–358.

Small, I. A., et al.. (2024). The prognostic role of PD-L1 expression and the presence of polyomavirus in Merkel cell carcinoma cases. Infectious Agents and Cancer. 19(1). 1–1. 1 indexed citations

Silva, Jessé Lopes da, et al.. (2023). Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status. PLoS ONE. 18(5). e0285447–e0285447. 1 indexed citations

Araújo, Rodrigo Otávio, et al.. (2022). Induction Chemotherapy and Chemoradiotherapy Combined to ASA vs. Placebo for High-Risk Rectal Cancer: Results of a Randomized Trial. Clinical Colorectal Cancer. 21(3). e196–e204. 2 indexed citations

Silva, Jessé Lopes da, et al.. (2020). Sociodemographic, Clinical, and Pathological Factors Influencing Outcomes in Locally Advanced Triple Negative Breast Cancer: A Brazilian Cohort. Breast Cancer Basic and Clinical Research. 14. 2222519992–2222519992. 3 indexed citations

Antunes, Héliton Spíndola, Daniel Herchenhorn, I. A. Small, et al.. (2015). Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation. Oral Oncology. 52. 85–90. 48 indexed citations

Antunes, Héliton Spíndola, Daniel Herchenhorn, I. A. Small, et al.. (2013). Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiotherapy and Oncology. 109(2). 297–302. 96 indexed citations

Valadão, Marcus, Danielle Braggio, Eduardo Linhares, et al.. (2012). Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients. Journal of Surgical Research. 178(1). 288–293. 12 indexed citations

Baldotto, Clarissa, Eduardo Cronemberger, Mauro Zamboni, et al.. (2012). Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?. Supportive Care in Cancer. 20(11). 2721–2727. 23 indexed citations

10.

Small, I. A., et al.. (2011). Tratamento adjuvante em câncer de pulmão de células não pequenas. Jornal Brasileiro de Pneumologia. 37(3). 354–359. 4 indexed citations

11.

Spector, Nelson, et al.. (2010). Influence of Sentinel Lymph Node Tumor Burden on Survival in Melanoma. Annals of Surgical Oncology. 17(4). 1152–1158. 26 indexed citations

12.

Antunes, Héliton Spíndola, et al.. (2010). Streptococcal bacteraemia in patients submitted to hematopoietic stem cell transplantation: The role of tooth brushing and use of chlorhexidine. Medicina oral, patología oral y cirugía bucal. 15(2). e303–e309. 14 indexed citations

13.

Rosa, Arthur Accioly, et al.. (2010). Mitomycin-C– or Cisplatin-Based Chemoradiotherapy for Anal Canal Carcinoma: Long-Term Results. International Journal of Radiation Oncology*Biology*Physics. 79(2). 490–495. 25 indexed citations

14.

Herchenhorn, Daniel, Fernando Luiz Dias, Célia M. Viégas, et al.. (2010). Phase I/II Study of Erlotinib Combined With Cisplatin and Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 78(3). 696–702. 30 indexed citations

15.

Herchenhorn, Daniel, Fernando Luiz Dias, Carlos Gil Ferreira, et al.. (2008). Impact of Previous Tracheotomy as a Prognostic Factor in Patients with Locally Advanced Squamous Cell Carcinoma of the Larynx Submitted to Concomitant Chemotherapy and Radiation. ORL. 70(6). 381–388. 16 indexed citations

16.

Dienstmann, Rodrigo, et al.. (2008). Palliative Percutaneous Nephrostomy in Recurrent Cervical Cancer: A Retrospective Analysis of 50 Consecutive Cases. Journal of Pain and Symptom Management. 36(2). 185–190. 16 indexed citations

17.

Dienstmann, Rodrigo, Paula B. Andrade, Daniel Herchenhorn, et al.. (2008). XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy. Urologic Oncology Seminars and Original Investigations. 27(4). 382–390. 16 indexed citations

18.

Guimarães, Denise Peixoto, Geisilene Russano de Paiva Silva, Daniel M. Souza, et al.. (2008). Interferon‐inducible guanylate binding protein (GBP)‐2: A novel p53‐regulated tumor marker in esophageal squamous cell carcinomas. International Journal of Cancer. 124(2). 272–279. 39 indexed citations

19.

Pontes, Elenir Rose Jardim Cury, Bruno L. Diaz, I. A. Small, et al.. (2006). Auto-antibodies in prostate cancer: Humoral immune response to antigenic determinants coded by the differentially expressed transcripts FLJ23438 and VAMP3. The Prostate. 66(14). 1463–1473. 8 indexed citations

20.

Small, I. A., et al.. (2006). Outcomes of advanced stage non-small cell lung cancer (NSCLC) patients reexposed to platinum-based chemotherapy upon progression. Journal of Clinical Oncology. 24(18_suppl). 17136–17136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact